The Food and Drug Administration recently approved Orkambi a new cystic fibrosis treatment that received designation from the FDA as a breakthrough therapy and as an orphan drug.
Teva Pharmaceuticals announced the U.S.-wide availability of generic Aggrenox (aspirin and extended-release dipyridamole) capsules, which contain that can reduce the risk of stroke, on Wednesday.
The American Pharmacists Association requests applicants for the APhA Board of Trustees, APhA-Academy of Pharmacy Practice and Management and APhA-Academy of Pharmaceutical Research and Science.
DSNTV recently met with CVS Health's store leadership team in New York City to walk through one of the company’s new stores and learn more about the big changes unfolding in the aisles.
The Food and Drug Administration on Tuesday issued guidance indicating that the agency would give pharmacies an additional four months to comply with product tracing requirements scheduled to take effect July 1, 2015.
The International Generic Pharmaceutical Alliance has issued a statement calling on parties negotiating the Trans-Pacific Partnership to make access to affordable medication a priority.
The GPhA's Biosimilars Council cautions FDA against adopting distinguishable names for biosimilars and biologics.
Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.
Pharmacy organizations have written a joint letter to the Food and Drug Administration asking officials to delay enforcement of a July 1 electronic product-tracing deadline for prescription drug dispensers.